357 related articles for article (PubMed ID: 26670195)
1. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.
Zheng S; Liu J; Wu Y; Huang TL; Wang G
Future Med Chem; 2015; 7(18):2485-505. PubMed ID: 26670195
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen.
Mallinger A; Crumpler S; Pichowicz M; Waalboer D; Stubbs M; Adeniji-Popoola O; Wood B; Smith E; Thai C; Henley AT; Georgi K; Court W; Hobbs S; Box G; Ortiz-Ruiz MJ; Valenti M; De Haven Brandon A; TePoele R; Leuthner B; Workman P; Aherne W; Poeschke O; Dale T; Wienke D; Esdar C; Rohdich F; Raynaud F; Clarke PA; Eccles SA; Stieber F; Schiemann K; Blagg J
J Med Chem; 2015 Feb; 58(4):1717-35. PubMed ID: 25680029
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
Catrow JL; Zhang Y; Zhang M; Ji H
J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer.
Hadden MK
Curr Med Chem; 2015; 22(35):4031-2. PubMed ID: 26630931
[No Abstract] [Full Text] [Related]
6. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
[TBL] [Abstract][Full Text] [Related]
7. Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled.
Lee HJ; Bao J; Miller A; Zhang C; Wu J; Baday YC; Guibao C; Li L; Wu D; Zheng JJ
J Biol Chem; 2015 Dec; 290(51):30596-606. PubMed ID: 26504084
[TBL] [Abstract][Full Text] [Related]
8. Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine.
Lum L; Chen C
Curr Med Chem; 2015; 22(35):4091-103. PubMed ID: 26310918
[TBL] [Abstract][Full Text] [Related]
9. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
10. Small Molecules Inspired by the Natural Product Withanolides as Potent Inhibitors of Wnt Signaling.
Sheremet M; Kapoor S; Schröder P; Kumar K; Ziegler S; Waldmann H
Chembiochem; 2017 Sep; 18(18):1797-1806. PubMed ID: 28678390
[TBL] [Abstract][Full Text] [Related]
11. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway.
Nencini A; Pratelli C; Quinn JM; Salerno M; Tunici P; De Robertis A; Valensin S; Mennillo F; Rossi M; Bakker A; Benicchi T; Cappelli F; Turlizzi E; Nibbio M; Caradonna NP; Zanelli U; Andreini M; Magnani M; Varrone M
Eur J Med Chem; 2015 May; 95():526-45. PubMed ID: 25847770
[TBL] [Abstract][Full Text] [Related]
13. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Shah K; Panchal S; Patel B
Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Zhang J; Jiang X; Jiang Y; Guo M; Zhang S; Li J; He J; Liu J; Wang J; Ouyang L
Eur J Med Chem; 2016 Jan; 108():495-504. PubMed ID: 26717201
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
[TBL] [Abstract][Full Text] [Related]
16. Development of anticancer agents targeting the Hedgehog signaling.
Zhang X; Tian Y; Yang Y; Hao J
Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894
[TBL] [Abstract][Full Text] [Related]
17. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics.
Kim DH; Sim T
Arch Pharm Res; 2012 Mar; 35(4):605-15. PubMed ID: 22553052
[TBL] [Abstract][Full Text] [Related]
18. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
Verma SK; Knight SD
Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
[TBL] [Abstract][Full Text] [Related]
20. Small molecule modulators of Wnt/β-catenin signaling.
Mook RA; Chen M; Lu J; Barak LS; Lyerly HK; Chen W
Bioorg Med Chem Lett; 2013 Apr; 23(7):2187-91. PubMed ID: 23453073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
